Strolll

Strolll is a software-as-a-medical-device (SaMD) company developing digital therapeutics for neurorehabilitation through augmented reality (AR). The company was founded in 2018, with Tom Finn being inspired after seeing how simple visual cues helped his father, who has vascular parkinsonism, improve his mobility. Jorgen Ellis joined as co-founder and CEO in 2020, bringing previous startup experience to the venture. The company's core mission is to make movement therapy more engaging and accessible for people with neurological disorders such as Parkinson’s disease, stroke, and Multiple Sclerosis.

The firm's main offering, Reality DTx®, is a software platform used with commercially available AR glasses, like the Microsoft HoloLens, to deliver gamified physiotherapy exercises and cueing strategies. This technology superimposes digital elements and virtual markers onto the user's real-world environment, allowing them to remain aware of their surroundings. The system is designed for use in both clinical and home settings, enabling therapists to prescribe, monitor, and adjust rehabilitation remotely. This model can reportedly increase the amount of therapy a patient receives by up to seven times while using significantly less of a clinician's time. Exercises focus on improving gait, balance, and hand-eye coordination, with the goal of increasing patient mobility, confidence, and independence.

Strolll operates on a business-to-business model, selling its platform to healthcare providers like hospitals and rehabilitation clinics rather than directly to consumers. The company has established partnerships with several NHS trusts in the UK and major healthcare providers in the US, including a significant collaboration with the Cleveland Clinic. The Stafford-based company has secured substantial funding to support its growth, including a €12.2 million Series A round in March 2025 and an additional €5 million in funding and loans from Innovate UK in September 2026. This capital is being used to accelerate sales, expand its regulatory approvals for additional conditions, and further develop its product line, which includes StrolllAssessment and StrolllAcute for bed-bound patients.

Keywords: neurorehabilitation, augmented reality, digital therapeutics, Parkinson's disease, stroke rehabilitation, multiple sclerosis, movement therapy, MedTech, software-as-a-medical-device, SaMD, gait and balance, remote monitoring, physiotherapy, clinician tools, home rehabilitation, AR glasses, visual cues, gamified therapy, neurological disorders, Cleveland Clinic, NHS, Jorgen Ellis, Tom Finn, StrolllAssessment, StrolllAcute, Reality DTx